Results 201 to 210 of about 304,534 (261)

The Development and Pilot Clinical Study of CD147 Targeted Antagonistic Peptide Probe for Tumor Imaging

Advanced Science, EarlyView.
This study establishes [68Ga]Ga‐DOTA‐AP9 as a first‐in‐human CD147‐targeted PET tracer with favorable safety and specific tumor uptake. Tracer accumulation correlates with CD147 expression in patients, enabling noninvasive quantification of CD147‐positive malignancies.
Xiaokun Ma, Rui Guo, Dongfeng Niu, Yufei Song, Zhenyao Zhang, Xiangxi Meng, Lili Mao, Haifeng Huang, Hua Zhu, Zhi Yang, Teli Liu   +10 more
wiley   +1 more source

Adverse drug reaction signal detection via the long short-term memory model. [PDF]

Front Pharmacol
Cao M, Chi Y, Yu J, Yang Y, Meng R, Jia J.   +5 more
europepmc   +1 more source

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

Advanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang, Kejia Li, Ning Wang, Zhen Li, Zhiyong Zhang, Rocky S. Tuan, Yangzi Jiang   +6 more
wiley   +1 more source

AI-driven pharmacovigilance: Enhancing adverse drug reaction detection with deep learning and NLP. [PDF]

MethodsX
Khemani DB, Malave DS, Shinde S, Shukla M, Shikalgar R, Talwar H.   +5 more
europepmc   +1 more source

Enhancing adverse drug reaction data quality in Canada: A high-precision pipeline for medication name standardization and enrichment. [PDF]

PLoS One
Chalabianloo N, Abdullah SS, Omrani MA, Jafari A, Sedig K, Muanda FT.   +5 more
europepmc   +1 more source

DeepADR: multimodal prediction of adverse drug reaction frequency by integrating early-stage drug discovery information via Kolmogorov-Arnold networks. [PDF]

Brief Bioinform
Wan J, Jia C, Dong D, Chen Y, Lin YC, He Y, Huang HY, Huang HD.   +7 more
europepmc   +1 more source

Adverse drug reaction reporting with the Med Safety app in Uganda: a cluster-randomised, controlled trial.

Lancet Glob Health
Kiguba R, Ndagije HB, Mwebaza N, Ssenyonga R, Giibwa L, Isabirye G, Owiny J, Nambasa V, Ntale I, Atuhaire J, Mwesigwa D, Mayengo J, Walusimbi D, Mugisa I, Katureebe C, Harrison K, Karamagi C, Pirmohamed M.   +17 more
europepmc   +1 more source

Spontaneous Adverse Drug Reaction Reporting of Congenital Malformations: A Danish National Register Study. [PDF]

Pharmaceuticals (Basel)
Lausten-Thomsen U, Olsen RH, Christiansen M, Hedley PL, Heerfordt IM, Andersen JT, Gade C.   +6 more
europepmc   +1 more source

Descriptive study of adverse drug reaction patterns with antineoplastic and immunomodulating agents reported to the National Pharmacovigilance Centre in Saudi Arabia (2018-2020): A retrospective analysis. [PDF]

Medicine (Baltimore)
Bannan DF, Fouda MI, Alshammari RH, Alkahtani RM, Alsaggabi RA, Almuteri WM, Bahakeem S, Assiri GA, Alanizi AH, Alshibani M, Alshehri GH.   +10 more
europepmc   +1 more source